Theaflavins counteract free fatty acid-driven oxidative-inflammatory injury in endothelial cells through Nrf2-NF-κB axis - Report - MDSpire

Theaflavins counteract free fatty acid-driven oxidative-inflammatory injury in endothelial cells through Nrf2-NF-κB axis

  • By

  • Yufei Zhao

  • Biao Qu

  • June 9, 2026

  • 0 min

Share

Theaflavins Mitigate Oxidative and Inflammatory Damage Induced by Free Fatty Acids

Overview

Theaflavins (TFs) significantly reduce oxidative stress and inflammation caused by free fatty acids (FFAs) in endothelial cells and hepatocytes, with TF1 showing the most potent effects. This protective mechanism involves the Nrf2-NF-κB pathway, enhancing antioxidant responses while suppressing inflammatory signaling.

Background

Chronic elevation of circulating FFAs is a major contributor to metabolic and cardiovascular diseases, leading to endothelial dysfunction and lipotoxic injury. Understanding the protective effects of dietary compounds like theaflavins could provide insights into potential therapeutic strategies for managing these conditions.

Data Highlights

Theaflavin SubtypeEffect on ROSEffect on Lipid PeroxidationEffect on Inflammatory Mediators
TF1Significant reductionSignificant reductionSignificant reduction
TF2AModerate reductionModerate reductionModerate reduction
TF2BModerate reductionModerate reductionModerate reduction
TFDGModerate reductionModerate reductionModerate reduction

Key Findings

  • All TF subtypes reduced FFA-induced ROS overproduction and lipid peroxidation.
  • TF1 exhibited the strongest cytoprotective effects among the four subtypes.
  • TF1 activated Nrf2, promoting antioxidant gene expression and inhibiting inflammatory pathways.
  • Silencing Nrf2 diminished the protective effects of TF1, highlighting its critical role.
  • TFs restored cellular redox homeostasis through both direct scavenging and enhancing endogenous defenses.

Clinical Implications

The findings suggest that theaflavins, particularly TF1, may serve as a dietary intervention to mitigate oxidative and inflammatory damage in conditions associated with elevated FFAs. Incorporating these compounds into clinical practice could enhance endothelial function and reduce cardiovascular risk.

Conclusion

Theaflavins represent a promising natural approach to counteract FFA-induced endothelial dysfunction, with TF1 emerging as a key agent through its modulation of the Nrf2-NF-κB pathway.

Related Resources & Content

  1. Kaplowitz, N., Archives of Toxicology, 2005 -- Induction of the Nrf2 Pathway by Hepatotoxic Medications is Linked to Inhibition of NF-κB Activation and Increased Vulnerability to TNFα-Induced Cell Death
  2. Archives of Toxicology, 2026 -- Okadaic acid triggers NFκB and STAT3 phosphorylation followed by a release of inflammatory markers in human and mouse endothelial cells
  3. Archives of Toxicology, 2025 -- Flavonoids' Role in Mitigating Toxicity Induced by Silver Nanoparticles
  4. Archives of Toxicology, 2021 -- Nrf2: A Key Regulator in Cellular Response to Mycotoxin-Induced Toxicity
  5. Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases - PubMed
  6. The effects of whole foods and dietary patterns on flow-mediated dilation: a systematic review and meta-analysis of randomized controlled trials - The American Journal of Clinical Nutrition
  7. Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases - PubMed
  8. The effects of whole foods and dietary patterns on flow-mediated dilation: a systematic review and meta-analysis of randomized controlled trials - The American Journal of Clinical Nutrition

Original Source(s)

Related Content